AAAAAA
Results: 1-25/36
Authors:
Rose, PG
Citation: Pg. Rose, Re: Annual report to the nation on the status of cancer (1973 through 1998), featuring cancer with recent increasing trends, J NAT CANC, 93(21), 2001, pp. 1656-1656
Authors:
Rose, PG
Eifel, PJ
Citation: Pg. Rose et Pj. Eifel, Combined radiation therapy and chemotherapy for carcinoma of the cervix, CANCER J, 7(2), 2001, pp. 86-94
Authors:
Rose, PG
Citation: Pg. Rose, Locally advanced cervical cancer, CUR OP OBST, 13(1), 2001, pp. 65-70
Authors:
Curtin, JP
Blessing, JA
Webster, KD
Rose, PG
Mayer, AR
Fowler, WC
Malfetano, JH
Alvarez, RD
Citation: Jp. Curtin et al., Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: A Gynecologic Oncology Group Study, J CL ONCOL, 19(5), 2001, pp. 1275-1278
Authors:
Fracasso, PM
Brady, MF
Moore, DH
Walker, JL
Rose, PG
Letvak, L
Grogan, TM
McGuire, WP
Citation: Pm. Fracasso et al., Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovariancarcinoma: A gynecologic oncology group study, J CL ONCOL, 19(12), 2001, pp. 2975-2982
Authors:
Rodriguez, M
Rose, PG
Citation: M. Rodriguez et Pg. Rose, Improved therapeutic index of lower dose topotecan chemotherapy in recurrent ovarian cancer, GYNECOL ONC, 83(2), 2001, pp. 257-262
Authors:
Rose, PG
Maxson, JH
Fusco, N
Mossbruger, K
Rodriguez, M
Citation: Pg. Rose et al., Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: A retrospective comparative study of single-agent dosages, GYNECOL ONC, 82(2), 2001, pp. 323-328
Authors:
Rose, PG
Citation: Pg. Rose, Chemotherapy in the treatment of locally advanced cervical cancer during pregnancy, GYNECOL ONC, 82(2), 2001, pp. 409-409
Authors:
Rose, PG
Faulhaber, P
Miraldi, F
Abdul-Karim, FW
Citation: Pg. Rose et al., Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: Correlation with second-look laparotomy, GYNECOL ONC, 82(1), 2001, pp. 17-21
Authors:
Rose, PG
Citation: Pg. Rose, Type II radical hysterectomy: Evaluating its role in cervical cancer, GYNECOL ONC, 80(1), 2001, pp. 1-2
Authors:
Rodriguez, M
Guimares, O
Rose, PG
Citation: M. Rodriguez et al., Radical abdominal trachelectomy and pelvic lymphadenectomy with uterine conservation and subsequent pregnancy in the treatment of early invasive cervical cancer, AM J OBST G, 185(2), 2001, pp. 370-374
Authors:
Sarode, VR
Rader, AE
Rose, PG
Rodriguez, M
Abdul-Karim, FW
Citation: Vr. Sarode et al., Significance of cytologically normal endometrial cells in cervical smears from postmenopausal women, ACT CYTOL, 45(2), 2001, pp. 153-156
Authors:
Gordon, AN
Granai, CO
Rose, PG
Hainsworth, J
Lopez, A
Weissman, C
Rosales, R
Sharpington, T
Citation: An. Gordon et al., Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer, J CL ONCOL, 18(17), 2000, pp. 3093-3100
Authors:
Rose, PG
Rodriguez, M
Waggoner, S
Greer, BE
Horowitz, IR
Fowler, JM
McGuire, WP
Citation: Pg. Rose et al., Phase I study of paclitaxel, carboplatin, and increasing days of prolongedoral etoposide in ovarian, peritoneal, and tubal carcinoma: A Gynecologic Oncology Group study, J CL ONCOL, 18(16), 2000, pp. 2957-2962
Authors:
Rose, PG
Citation: Pg. Rose, Surgery for recurrent ovarian cancer, SEMIN ONCOL, 27(3), 2000, pp. 17-23
Authors:
Nakamura, H
Rose, PG
Blumer, JL
Reed, MD
Citation: H. Nakamura et al., Acute encephalopathy due to aluminum toxicity successfully treated by combined intravenous deferoxamine and hemodialysis, J CLIN PHAR, 40(3), 2000, pp. 296-300
Authors:
Rose, PG
Brunetto, VL
VanLe, L
Bell, J
Walker, JL
Lee, RB
Citation: Pg. Rose et al., A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: A gynecologic oncology group study, GYNECOL ONC, 78(2), 2000, pp. 212-216
Authors:
Rose, PG
Gordon, NH
Fusco, N
Fluellen, L
Rodriguez, M
Ingalls, ST
Hoppel, CL
Citation: Pg. Rose et al., A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma, GYNECOL ONC, 78(2), 2000, pp. 228-234
Authors:
Rose, PG
Lappas, PT
Citation: Pg. Rose et Pt. Lappas, Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: Implications from five randomized trials, GYNECOL ONC, 78(1), 2000, pp. 3-6
Authors:
Rose, PG
Shrigley, R
Wiesner, GL
Citation: Pg. Rose et al., Germline BRCA2 mutation in a patient with fallopian tube carcinoma: A casereport, GYNECOL ONC, 77(2), 2000, pp. 319-320
Authors:
Rose, PG
Berkowitz, RS
Citation: Pg. Rose et Rs. Berkowitz, Advances in the management of cervical cancer, J REPRO MED, 45(12), 2000, pp. 971-978
Authors:
Rose, PG
Citation: Pg. Rose, Chemoradiotherapy - The new standard care for invasive cervical cancer, DRUGS, 60(6), 2000, pp. 1239-1244
Authors:
Rose, PG
Alvarez, B
MacLennan, GT
Citation: Pg. Rose et al., Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure, AM J OBST G, 183(2), 2000, pp. 507-508
Authors:
Rose, PG
Fusco, N
Fluellen, L
Rodriguez, M
Citation: Pg. Rose et al., Tolerance of twenty-four hour paclitaxel and carboplatin as first-line therapy in ovarian, peritoneal and fallopian tube carcinoma, INT J GYN C, 9(6), 1999, pp. 448-451
Authors:
Rose, PG
Citation: Pg. Rose, Skin bridge recurrences in vulvar cancer: frequency and management, INT J GYN C, 9(6), 1999, pp. 508-511